Look for a New Colchicine 0.5 mg to Reduce CV Risk
December 2023
You may see some home meds lists include colchicine (Lodoco) 0.5 mg for chronic coronary disease.
It’s not a transcription error. Instead of the 0.6 mg we’re used to using for gout, Lodoco is 0.5 mg...and the first colchicine approved to reduce CV risk.
There’s been growing interest in using colchicine to reduce CV risk...due to its anti-inflammatory effect.
Get concise advice on drug therapy, plus unlimited access to CE
Hospital Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote